|
INTS7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.786410E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.250000E-02 |
| Normal-vs-Stage2 |
2.660800E-03 |
| Normal-vs-Stage3 |
2.028500E-02 |
| Normal-vs-Stage4 |
8.496200E-02 |
| Stage1-vs-Stage2 |
6.078300E-02 |
| Stage1-vs-Stage3 |
2.387000E-01 |
| Stage1-vs-Stage4 |
6.142800E-01 |
| Stage2-vs-Stage3 |
3.170000E-01 |
| Stage2-vs-Stage4 |
2.290600E-01 |
| Stage3-vs-Stage4 |
7.098400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.086100E-02 |
| Normal-vs-AfricanAmerican |
9.345400E-01 |
| Normal-vs-Asian |
5.341000E-01 |
| Caucasian-vs-AfricanAmerican |
1.573960E-01 |
| Caucasian-vs-Asian |
2.343400E-01 |
| AfricanAmerican-vs-Asian |
6.945600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.173790E-02 |
| Normal-vs-Female |
3.620300E-02 |
| Male-vs-Female |
3.323400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.205000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.955300E-03 |
| Normal-vs-Age(61-80Yrs) |
5.303600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.042000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.341570E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.411600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.909700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.242800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.504000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.330200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.169800E-01 |
| Classical-VS-Follicular |
1.260150E-03 |
| Classical-VS-Other |
1.640790E-01 |
| Classical-VS-Normal |
1.770830E-01 |
| Tall-VS-Follicular |
5.594400E-02 |
| Tall-VS-Other |
1.188620E-01 |
| Tall-VS-Normal |
2.906000E-01 |
| Follicular-VS-Other |
7.485200E-01 |
| Follicular-VS-Normal |
6.162100E-04 |
| Other-VS-Normal |
3.056300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.920400E-03 |
| Normal-vs-N1 |
7.339700E-02 |
| N0-vs-N1 |
6.122800E-01 |
|
|
